| Name | Title | Contact Details |
|---|
We empower greater health. Today, we have access to highly personalized and useful information in almost every area of our lives; our money, transportation, food, exercise, entertainment, and home security yet we don’t have this same access to the data and insights contained in our personal health records. The current healthcare system is highly complex and constrains the flow of useful information; patient health data and medical records are stored in hundreds of different systems, across thousands of independent organizations in millions of different formats. We simplify this complexity to securely connect healthcare decision-makers to the clinical data and hidden insights contained in patent medical records so that they can deliver greater outcomes at lower costs.
IQVIA is a leading global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find better solutions for their patients. Formed through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward. IQVIA enables companies to rethink approaches to clinical development and commercialization, innovate with confidence as well as accelerate meaningful healthcare outcomes. IQVIA has approximately 55,000 employees in more than 100 countries, all committed to making the potential of human data science a reality. IQVIAs approach to human data science is powered by the IQVIA CORE™, driving unique actionable insights at the intersection of big data, transformative technology and analytics with extensive domain expertise.
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.
Health Education Alliance is a White Plains, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Links Medical Products is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Irvine, CA. To find more information about Links Medical Products, please visit www.linksmed.com